SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-106441
Filing Date
2023-10-03
Accepted
2023-10-03 16:59:45
Documents
14
Period of Report
2023-10-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2327587d1_8k.htm   iXBRL 8-K 26898
2 EXHIBIT 99.1 tm2327587d1_ex99-1.htm EX-99.1 42109
6 GRAPHIC tm2327587d1_img1.jpg GRAPHIC 2465
  Complete submission text file 0001104659-23-106441.txt   253498

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nvax-20231003.xsd EX-101.SCH 3012
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20231003_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20231003_pre.xml EX-101.PRE 22357
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2327587d1_8k_htm.xml XML 3206
Mailing Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878
Business Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 231304994
SIC: 2836 Biological Products, (No Diagnostic Substances)